EUVIMEDEUVIMED entdecken
Crossref

Lyophilized LAMP Assay Combined with Lateral Flow Biosensor for Cold-Chain-Free Detection of Mycobacterium tuberculosis

Jutturong Ckumdee, Somchai Santiwatanakul, Nakarin Vutipow iD, Thongchai Kaewphinit iD

ACS Infectious Diseases · 14.08.2026 · 12 (8) · 2853-2862

DOI: 10.1021/acsinfecdis.6c00520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 22.07.2026. Verfasst von Jutturong Ckumdee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok10300, Thailand. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Biosensing Techniques, Nucleic Acid Amplification Techniques, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Srinakharinwirot University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To decentralize tuberculosis surveillance in resource-limited and tropical regions, a rapid, robust, and cold-chain-independent near-point-of-care biosensor is urgently required to overcome the instability of conventional liquid-formulation diagnostics. Herein, we developed a ready-to-use lyophilized reaction mix Loop-Mediated Isothermal Amplification (LAMP) matrix integrated with a Lateral Flow Biosensor (LFB) for the instrument-free visual detection of Mycobacterium tuberculosis (M. tuberculosis). The freeze-dried reagents, stabilized with an optimized trehalose-BSA matrix, were hermetically packaged and systematically evaluated for long-term thermal stability across four regulated profiles (−20 °C, 4 °C, 25 °C, and 37 °C) over a 12-month period. Diagnostic viability was further validated in a double-blinded study using 191 clinical sputum specimens against gold-standard culture and line probe assays. The stabilized platform demonstrated an analytical sensitivity down to 102 CFU/mL and maintained full functional activity for up to 12 months at −20 °C and 4 weeks at 4 °C, with robust short-term resilience under tropical stress (25 °C) for up to 1 week. However, the formulation was unable to withstand prolonged exposure to harsh environmental conditions at 37 °C, resulting in a progressive decline in amplification performance following phase-transition instability. Crucially, clinical validation yielded an outstanding diagnostic sensitivity of 98.92% and a positive predictive value (PPV) of 100.00%. These findings validate the lyophilized LAMP-LFB platform as a highly reliable, sustainable, and distributable molecular diagnostic tool capable of overcoming the cold-chain bottleneck in field-based tuberculosis detection. Although the developed platform shows strong potential for near-point-of-care deployment, further optimization of the lyophilization formulation and process will be necessary to enable prolonged storage and transportation under ambient-temperature conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisBiosensing TechniquesNucleic Acid Amplification TechniquesTuberculosisMolecular Diagnostic TechniquesFreeze DryingHumansRapid Diagnostic TestsSensitivity and SpecificitySputum

Stichwörter der Autor:innen

Mycobacterium tuberculosislateral flow biosensorloop-mediated isothermal amplification (LAMP)lyophilizationpoint-of-care testingthermal stability

Autor:innen und Institutionen

  • Department of Clinical Pathology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok10300, Thailand.
  • Department of Pathology, Faculty of Medicine, Srinakharinwirot University, Bangkok, Nakhon Nayok Province26120, Thailand.
  • Genetic Engineering and Bioinformatics Interdisciplinary Program, Graduate School, Kasetsart University, Bangkok10900, Thailand.
  • Center of Excellence in Medical and Environmental Innovation Research (CEMEIR), Srinakharinwirot University, Bangkok10110, Thailand.
  • Innovative Learning Center, Srinakharinwirot University, Bangkok10110, Thailand.

ORCID-Profile: Nakarin Vutipow, Thongchai Kaewphinit

Förderung

  • Srinakharinwirot University

Zitieren

APA

Ckumdee, J., Santiwatanakul, S., Vutipow, N., & Kaewphinit, T. (2026). Lyophilized LAMP Assay Combined with Lateral Flow Biosensor for Cold-Chain-Free Detection of Mycobacterium tuberculosis. ACS Infectious Diseases, 12(8), 2853-2862. https://doi.org/10.1021/acsinfecdis.6c00520

Vancouver

Ckumdee J, Santiwatanakul S, Vutipow N, Kaewphinit T. Lyophilized LAMP Assay Combined with Lateral Flow Biosensor for Cold-Chain-Free Detection of Mycobacterium tuberculosis. ACS Infectious Diseases. 2026;12(8):2853-2862. doi:10.1021/acsinfecdis.6c00520

BibTeX
@article{Ckumdee2026,
  author = {Ckumdee, Jutturong and Santiwatanakul, Somchai and Vutipow, Nakarin and Kaewphinit, Thongchai},
  title = {Lyophilized LAMP Assay Combined with Lateral Flow Biosensor for Cold-Chain-Free Detection of Mycobacterium tuberculosis},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {8},
  pages = {2853--2862},
  doi = {10.1021/acsinfecdis.6c00520}
}
Kostenlos starten →